Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure.

Odile Humbert1, Ikbel Achour, Dominique Lautier

  • 1Institut de Pharmacologie et de Biologie Structurale, UMR 5089 CNRS, 205, Route de Narbonne, 31077, Toulouse Cedex, France. odile.humbert@ipbs.fr

Nucleic Acids Research
|September 23, 2003
PubMed
Summary

Protein kinase C (PKC) activation upregulates human MutS homolog 2 (hMSH2) expression via transcriptional control. This process involves the AP-1 transcription factor binding to the hMSH2 promoter, crucial for DNA repair and genomic stability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1/CTLA-4 bispecific antibody.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

The DExD-box RNA helicase Dbp7 unwinds short double-stranded RNAs.

Biochimie·2026
Same author

Quality of life of female partners of patients who underwent penile prosthesis implantation: A multicenter retrospective study.

The French journal of urology·2026
Same author

The snoRNP chaperone snR190 and the Npa1 complex form a macromolecular assembly required for 60S ribosomal subunit maturation.

Nucleic acids research·2025
Same author

Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response.

Cell reports. Medicine·2024
Same author

Clinical Validation of Mathematically Derived Early Tumor Dynamics for Solid Tumors in Response to Durvalumab.

JCO clinical cancer informatics·2024

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Mammalian mismatch repair (MMR) is vital for genomic stability and cellular response to DNA damage.
  • Understanding the regulation of key MMR proteins like human MutS homolog 2 (hMSH2) is crucial for comprehending MMR dysfunction and its cellular consequences.
  • Previous studies indicated protein kinase C (PKC) activity regulates hMSH2 expression in myeloid leukemic cells.

Purpose of the Study:

  • To elucidate the regulatory mechanisms controlling hMSH2 expression.
  • To investigate the role of protein kinase C (PKC) in modulating hMSH2 levels.
  • To identify transcription factors involved in the PKC-mediated regulation of hMSH2.

Main Methods:

  • Treatment of U937 cells with phorbol ester (TPA) to activate PKC.

Related Experiment Videos

  • Analysis of hMSH2 protein and mRNA levels.
  • Investigation of hMSH2 promoter activity using site-directed mutagenesis of AP-1 binding sites.
  • Utilizing a dominant-negative c-Jun factor to assess AP-1's role in vivo and in vitro.
  • Main Results:

    • PKC activation by TPA leads to increased hMSH2 protein levels, paralleled by elevated hMSH2 mRNA.
    • Results suggest transcriptional regulation of the hMSH2 gene upon TPA induction.
    • The AP-1 transcription factor is implicated in the transactivation of hMSH2.
    • Disruption of AP-1 binding sites or inhibition of c-Jun abolished TPA-induced hMSH2 overexpression.

    Conclusions:

    • PKC-mediated control of hMSH2 expression is, at least partially, dependent on AP-1 transactivation.
    • The findings highlight AP-1 as a key mediator in the transcriptional upregulation of hMSH2 by PKC.
    • This regulatory pathway is important for maintaining genomic stability through the MMR system.